J NATL CANCER CTR 润色咨询

Journal of the National Cancer Center

出版年份：2021 年文章数：暂无数据 投稿命中率： 开通期刊会员，数据随心看

出版周期：暂无数据 自引率：暂无数据 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2246589, encodeId=cdf5224658998, content=偏重的研究方向：癌症<br>经验分享：什么时候能进SCIE？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83errr36kXHkxMrTrTWhjLk5R5AP8icliajzIgADJQJA44lbuRtSLibGcic9LoIrQozonia1gIZW1tyqYyYw/132, createdBy=6aaa2069065, createdName=690137070_13522039, createdTime=Sat Jan 04 23:00:04 CST 2025, time=2025-01-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2246588, encodeId=e35822465881b, content=什么时候能进SCIE？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83errr36kXHkxMrTrTWhjLk5R5AP8icliajzIgADJQJA44lbuRtSLibGcic9LoIrQozonia1gIZW1tyqYyYw/132, createdBy=6aaa2069065, createdName=690137070_13522039, createdTime=Sat Jan 04 22:59:34 CST 2025, time=2025-01-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2185632, encodeId=249a218563289, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤;癌症;癌症报告<br>经验分享：国家癌症中心的杂志，未来定位是很高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Feb 03 11:16:34 CST 2024, time=2024-02-03, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2134892, encodeId=ce8a21348927a, content=希望获得更好的影响因子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcc75591601, createdName=ms1000000215655488, createdTime=Tue May 16 07:53:55 CST 2023, time=2023-05-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1218047, encodeId=d019121804ef0, content=预计2022年被pubmed收录，2023年被SCI收录，定位很高，值得投资。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon May 09 10:45:00 CST 2022, time=2022-05-09, status=1, ipAttribution=)]
    2025-01-04 690137070_13522039 来自广东省

    偏重的研究方向：癌症
    经验分享：什么时候能进SCIE？

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2246589, encodeId=cdf5224658998, content=偏重的研究方向：癌症<br>经验分享：什么时候能进SCIE？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83errr36kXHkxMrTrTWhjLk5R5AP8icliajzIgADJQJA44lbuRtSLibGcic9LoIrQozonia1gIZW1tyqYyYw/132, createdBy=6aaa2069065, createdName=690137070_13522039, createdTime=Sat Jan 04 23:00:04 CST 2025, time=2025-01-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2246588, encodeId=e35822465881b, content=什么时候能进SCIE？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83errr36kXHkxMrTrTWhjLk5R5AP8icliajzIgADJQJA44lbuRtSLibGcic9LoIrQozonia1gIZW1tyqYyYw/132, createdBy=6aaa2069065, createdName=690137070_13522039, createdTime=Sat Jan 04 22:59:34 CST 2025, time=2025-01-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2185632, encodeId=249a218563289, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤;癌症;癌症报告<br>经验分享：国家癌症中心的杂志，未来定位是很高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Feb 03 11:16:34 CST 2024, time=2024-02-03, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2134892, encodeId=ce8a21348927a, content=希望获得更好的影响因子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcc75591601, createdName=ms1000000215655488, createdTime=Tue May 16 07:53:55 CST 2023, time=2023-05-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1218047, encodeId=d019121804ef0, content=预计2022年被pubmed收录，2023年被SCI收录，定位很高，值得投资。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon May 09 10:45:00 CST 2022, time=2022-05-09, status=1, ipAttribution=)]
    2025-01-04 690137070_13522039 来自广东省

    什么时候能进SCIE？

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2246589, encodeId=cdf5224658998, content=偏重的研究方向：癌症<br>经验分享：什么时候能进SCIE？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83errr36kXHkxMrTrTWhjLk5R5AP8icliajzIgADJQJA44lbuRtSLibGcic9LoIrQozonia1gIZW1tyqYyYw/132, createdBy=6aaa2069065, createdName=690137070_13522039, createdTime=Sat Jan 04 23:00:04 CST 2025, time=2025-01-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2246588, encodeId=e35822465881b, content=什么时候能进SCIE？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83errr36kXHkxMrTrTWhjLk5R5AP8icliajzIgADJQJA44lbuRtSLibGcic9LoIrQozonia1gIZW1tyqYyYw/132, createdBy=6aaa2069065, createdName=690137070_13522039, createdTime=Sat Jan 04 22:59:34 CST 2025, time=2025-01-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2185632, encodeId=249a218563289, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤;癌症;癌症报告<br>经验分享：国家癌症中心的杂志，未来定位是很高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Feb 03 11:16:34 CST 2024, time=2024-02-03, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2134892, encodeId=ce8a21348927a, content=希望获得更好的影响因子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcc75591601, createdName=ms1000000215655488, createdTime=Tue May 16 07:53:55 CST 2023, time=2023-05-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1218047, encodeId=d019121804ef0, content=预计2022年被pubmed收录，2023年被SCI收录，定位很高，值得投资。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon May 09 10:45:00 CST 2022, time=2022-05-09, status=1, ipAttribution=)]
    2024-02-03 侠胆医心 来自加利福尼亚

    审稿速度:6.0 | 投稿命中率:25.0
    偏重的研究方向：肿瘤;癌症;癌症报告
    经验分享：国家癌症中心的杂志，未来定位是很高的

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2246589, encodeId=cdf5224658998, content=偏重的研究方向：癌症<br>经验分享：什么时候能进SCIE？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83errr36kXHkxMrTrTWhjLk5R5AP8icliajzIgADJQJA44lbuRtSLibGcic9LoIrQozonia1gIZW1tyqYyYw/132, createdBy=6aaa2069065, createdName=690137070_13522039, createdTime=Sat Jan 04 23:00:04 CST 2025, time=2025-01-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2246588, encodeId=e35822465881b, content=什么时候能进SCIE？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83errr36kXHkxMrTrTWhjLk5R5AP8icliajzIgADJQJA44lbuRtSLibGcic9LoIrQozonia1gIZW1tyqYyYw/132, createdBy=6aaa2069065, createdName=690137070_13522039, createdTime=Sat Jan 04 22:59:34 CST 2025, time=2025-01-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2185632, encodeId=249a218563289, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤;癌症;癌症报告<br>经验分享：国家癌症中心的杂志，未来定位是很高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Feb 03 11:16:34 CST 2024, time=2024-02-03, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2134892, encodeId=ce8a21348927a, content=希望获得更好的影响因子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcc75591601, createdName=ms1000000215655488, createdTime=Tue May 16 07:53:55 CST 2023, time=2023-05-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1218047, encodeId=d019121804ef0, content=预计2022年被pubmed收录，2023年被SCI收录，定位很高，值得投资。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon May 09 10:45:00 CST 2022, time=2022-05-09, status=1, ipAttribution=)]
    2023-05-16 ms1000000215655488 来自江苏省

    希望获得更好的影响因子

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2246589, encodeId=cdf5224658998, content=偏重的研究方向：癌症<br>经验分享：什么时候能进SCIE？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83errr36kXHkxMrTrTWhjLk5R5AP8icliajzIgADJQJA44lbuRtSLibGcic9LoIrQozonia1gIZW1tyqYyYw/132, createdBy=6aaa2069065, createdName=690137070_13522039, createdTime=Sat Jan 04 23:00:04 CST 2025, time=2025-01-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2246588, encodeId=e35822465881b, content=什么时候能进SCIE？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83errr36kXHkxMrTrTWhjLk5R5AP8icliajzIgADJQJA44lbuRtSLibGcic9LoIrQozonia1gIZW1tyqYyYw/132, createdBy=6aaa2069065, createdName=690137070_13522039, createdTime=Sat Jan 04 22:59:34 CST 2025, time=2025-01-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2185632, encodeId=249a218563289, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤;癌症;癌症报告<br>经验分享：国家癌症中心的杂志，未来定位是很高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Feb 03 11:16:34 CST 2024, time=2024-02-03, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2134892, encodeId=ce8a21348927a, content=希望获得更好的影响因子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcc75591601, createdName=ms1000000215655488, createdTime=Tue May 16 07:53:55 CST 2023, time=2023-05-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1218047, encodeId=d019121804ef0, content=预计2022年被pubmed收录，2023年被SCI收录，定位很高，值得投资。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon May 09 10:45:00 CST 2022, time=2022-05-09, status=1, ipAttribution=)]
    2022-05-09 古天乐

    预计2022年被pubmed收录，2023年被SCI收录，定位很高，值得投资。

    0

共6条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分